Clinical Trial Update: Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV) [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 single-dose safety study of a compound for postoperative nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Snippet

Sponsor: Accenture | Conditions: Post-Operative Nausea and Vomiting (PONV) | Phase 1 | Status: COMPLETED